EP Patent

EP3009435B1 — Apixaban glycol esters as key intermediates and impurities of the synthesis of Apixaban

Assigned to Fabbrica Italiana Sintetici SpA (FIS) · Expires 2016-08-17 · 10y expired

What this patent protects

Patent listed against pexidartinib-hydrochloride.

Drugs covered by this patent

pexidartinib-hydrochloride (PEXIDARTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: EP3009435B1
Jurisdiction: EP
Classification: —
Expires: 2016-08-17
Drug substance claim: No
Drug product claim: No
Assignee: Fabbrica Italiana Sintetici SpA (FIS)
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.